Clinical Investigation Evaluating the Performance, Safety and Clinical Benefit of the Endowave FlexAblate™ Microwave Ablation System in Patients Undergoing Lung Ablation Procedures.

The goal of this clinical trial is to learn if the FlexAblate™ Ablation System works to treat a lung cancer nodules and it will also learn about the safety of the ablation system. Participants in this clinical trial will be patients aged over 18 years who have been previously diagnosed with cancer in the lung (primary or secondary malignant tumours) and deemed unsuitable for surgery or are declining surgery or, patients suitable for microwave ablation procedure based on clinical assessment. Those who meet all of the eligibility criteria at a screening assessment (a review of eligibility to p

Trial Details

NCT ID
NCT07291973
Phase
NA
Sponsor
Endowave Ltd.
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • Microwave Ablation
Locations (sample)
  • Paris, France|48.85341,2.3488
  • London, United Kingdom|51.50853,-0.12574
  • London, United Kingdom|51.50853,-0.12574

Key Eligibility Criteria

  • Adult ≥ 18 years of age who has provided signed informed consent.
  • Subject is able and willing to comply with the planned clinical investigation follow-up schedule
  • Pathological confirmed malignant nodule in the lung either primary or metastatic disease.
  • Target nodule is ≤ 20mm in maximum diameter.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →